🌊New England Fishery Management Council Public Meeting Notice
The New England Fishery Management Council (Council) is scheduling a public meeting of its Joint Groundfish Advisory and Recreational Advisory Panels via webinar to consider actions affecting New England fisheries in the exclusive economic zone (EEZ). Recommendations from this group will be brought to the full Council for formal consideration and action, if appropriate.
Learn More🌎Upcoming Virtual Meeting Announcement - Environmental Management Board
This notice announces a virtual meeting of the Environmental Management Site-Specific Advisory Board (EM SSAB), Northern New Mexico. The Federal Advisory Committee Act requires that public notice of this meeting be announced in the Federal Register.
Learn More🪙CCAC Public Meeting Announcement by United States Mint
The Department of the Treasury announces a public meeting on September 16, 2025, held by the Citizens Coinage Advisory Committee (CCAC) to review potential designs for commemorative coins, including the Forgotten Heroes of the Holocaust Congressional Gold Medal. Public observation is through livestream, and submissions for consideration can be made via email.
Learn More📅Public Meeting Notice of Maryland Advisory Committee to USCCR
Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights (Commission) and the Federal Advisory Committee Act, that the Maryland Advisory Committee (Committee) to the U.S. Commission on Civil Rights will a public meeting via Zoom. The purpose is for the committee to discuss possible topics of study.
Learn More🏢TVA Public Meeting Agenda and Implications for Businesses
The Tennessee Valley Authority Board of Directors will convene a public meeting in Knoxville, Tennessee, to discuss various agenda items, including finance reports, governance updates, and stakeholder engagement. The meeting will feature a public listening session where comments are invited, fostering transparency and participation from community members and local businesses.
Learn More🗣️Notice of Ohio Advisory Committee Public Meeting on Civil Rights
Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights (Commission) and the Federal Advisory Committee Act, that the Ohio Advisory Committee (Committee) to the U.S. Commission on Civil Rights will hold a public meeting via Zoom. The purpose of this meeting is to debrief on testimony received from panel briefings I-III and determine the next course of action.
Learn More📅Cancellation Notice of Louisiana Advisory Committee Meeting
The Commission on Civil Rights published a notice in the Federal Register concerning a meeting of the Louisiana Advisory Committee. The meeting, scheduled for Thursday, August 21, 2025, at 10:00 a.m. CST, has been cancelled. The notice is in the Federal Register on Monday, August 4, 2025, in FR Document Number 2025-14714 on page 36419.
Learn More🏭NRC Seeks Public Comments on Oyster Creek Decommissioning Plan
The U.S. Nuclear Regulatory Commission (NRC) is considering a request from Holtec Decommissioning International, LLC (HDI) seeking approval of a license amendment application approving the license termination plan (LTP). The NRC requests public comments on the remaining decommissioning activities at the Oyster Creek Nuclear Generating Station (OCNGS) as described in the LTP amendment application for the OCNGS. The NRC plans to hold a public meeting to promote full understanding of the requested action and to facilitate public comment.
Learn More🧪FDA Announces Public Meeting on Biosimilar User Fee Act III
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled "Biosimilar User Fee Act (BsUFA) III Regulatory Science Program Interim Public Meeting" and the availability of the report entitled "BsUFA III Regulatory Science Pilot Program Interim Report." The purpose of the public meeting is to review the progress of the BsUFA III Regulatory Science Program aims, or demonstration projects, and to solicit input on future research priorities. Under the BsUFA reauthorization commitment letter for fiscal years (FYs) 2023 through 2027 (BsUFA III), FDA committed to piloting a regulatory science program to facilitate biosimilar and interchangeable product development that focuses on: (1) advancing the development of interchangeable products; and (2) improving the efficiency of biosimilar product development. The purpose of the interim progress report is to provide a summary of activities that established the pilot program, an overview of research progress, and a brief discussion of future directions.
Learn More💊National Advisory Council on Drug Abuse Meeting for Grant Review
The National Advisory Council on Drug Abuse announces a hybrid meeting to evaluate grant applications. The session includes both open and closed portions, discussing confidential information. Interested parties are invited to submit comments, with the meeting set to enhance collaboration on drug abuse research initiatives.
Learn More